Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Novo Nordisk A/S (NYSE:NVO)

53.78
Delayed Data
As of Jun 30
 +0.77 / +1.45%
Today’s Change
46.17
Today|||52-Week Range
60.34
-7.40%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2015
Quarter 3
2015
Quarter 4
2015
Quarter 1
2016
AssetsCash1.8B2.3B2.5B736.9M
 
 
 
 
 
Short Term Investment Cash847.9M558.4M146.2M-1.7B
 
 
 
 
 
Cash & Short Term Investments1.8B2.7B3.0B1.6B
 
 
 
 
 
 
ReceivablesReceivables2.9B2.7B3.0B3.1B
 
 
 
 
 
 
InventoriesInventories1.9B1.9B1.9B2.0B
 
 
 
 
 
 
Current AssetsPrepaid Expenses----127.9M--
 
 
Other Current Assets451.4M422.9M0.00401.8M
 
 
 
 
Current Assets7.1B7.7B8.0B7.1B
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross----7.4B--
 
 
Depreciation-----3.7B--
 
 
Intangible Assets218.1M219.2M314.1M329.9M
 
 
 
 
 
Other Assets218.1M219.2M314.1M329.9M
 
 
 
 
 
Total Assets12.1B12.7B13.4B12.6B
 
 
 
 
 
 
LiabilitiesAccounts Payable587.3M575.3M717.2M572.0M
 
 
 
 
 
Short Term Debt109.9M94.3M156.2M62.1M
 
 
 
 
 
Accrued Expenses----850.1M--
 
 
Other Current Liabilities4.6B4.6B3.9B4.9B
 
 
 
 
 
Other Liabilities5.8B5.8B5.9B6.3B
 
 
 
 
 
 
Total LiabilitiesDeferred Taxes-992.0M-923.8M-989.8M-917.1M
 
 
 
 
 
Other Liabilities0.000.000.000.00
 
 
Total Liabilities6.3B6.3B6.5B6.9B
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock0.000.000.000.00--
Common Equity5.8B6.5B6.8B5.7B
 
 
 
 
 
Total Shareholder Equity5.8B6.5B6.8B5.7B
 
 
 
 
 
 
Share InformationCommon Shares Outstanding2.1B2.1B2.0B2.1B
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.